A
37
-3
BA
43
-2
HCP
72
-2
VIX
25
-8
BAC
45
-5
XRX
45
-4
GD
59
-5
TSCO
51
-4
NVDA
59
5
ZBH
44
2
TRV
42
-3
NTRS
37
-7
GPC
43
5
M
36
2
SLB
60
3
KEY
43
-3
VFC
57
-5
HAL
53
3
MHK
43
-5
EXC
47
-4
A
37
-3
BA
43
-2
HCP
72
-2
VIX
25
-8
BAC
45
-5
XRX
45
-4
GD
59
-5
TSCO
51
-4
NVDA
59
5
ZBH
44
2
TRV
42
-3
NTRS
37
-7
GPC
43
5
M
36
2
SLB
60
3
KEY
43
-3
VFC
57
-5
HAL
53
3
MHK
43
-5
EXC
47
-4
Financhill
Back

SPDR® S&P Retail ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
66

XRT
SPDR® S&P Retail ETF

Last Price:
75.35
Seasonality Move:
2.84%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
40.35
Seasonality Move:
-0.9%
Buy
66
SPDR® S&P Retail ETF (XRT) is a Buy

Is SPDR® S&P Retail ETF a Buy, Sell or Hold?

  • The current SPDR® S&P Retail ETF [XRT] share price is $75.44. The Score for XRT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • XRT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XRT Stock Price Chart

What is SPDR® S&P Retail ETF's stock price today?

  • The SPDR® S&P Retail ETF share price today is $75.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XRT is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

XRT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 48.17 Sell
Chaikin Money Flow: -288398 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.86 - 77.04) Sell
Bollinger Bands (100): (72.53 - 76.91) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

XRT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.72 Sell
20-day SMA: 76.24 Sell
50-day SMA: 74.67 Buy
200-day SMA: 69.57 Buy
8-day EMA: 75.84 Sell
20-day EMA: 75.88 Sell
50-day EMA: 75.29 Buy
200-day EMA: 71.32 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

SPDR® S&P Retail ETF Earnings Growth & XRT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

SPDR® S&P Retail ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):